Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Wanbond: Expected net profit attributable to shareholders for January-March 2026 to be approximately 165 million yuan
Securities Star News: Wanbangde releases earnings forecast, expecting net profit attributable to shareholders of approximately 165 million yuan for January to March 2026.
The announcement explains the reasons for this performance change as follows:
The company has begun to see initial results from its strategic shift from generic drugs to innovative drugs. During the reporting period, business expansion made positive progress, bringing new growth points, and R&D efforts have been continuously increased.
During the reporting period, the company strengthened internal management, increased efforts to recover accounts receivable, and effectively accelerated cash inflows.
Wanbangde’s Q3 2025 report shows that the company’s main business revenue for the first three quarters was 1.018 billion yuan, a decrease of 5.28% year-on-year; net profit attributable to shareholders was 4.4678 million yuan, down 90.22% year-on-year; non-recurring net profit was -36.7232 million yuan, down 952.19% year-on-year; among them, in Q3 2025, the company’s quarterly main business revenue was 439 million yuan, up 36.51% year-on-year; quarterly net profit attributable to shareholders was -8.9957 million yuan, down 212.42% year-on-year; quarterly non-recurring net profit was -12.6089 million yuan, up 8.39% year-on-year; debt ratio is 39.09%, investment income is 0.0 yuan, financial expenses are 23.33 million yuan, and gross profit margin is 32.3%.
The above content is compiled by Securities Star based on publicly available information, generated by AI algorithms (Wangxin Calculation Backup 310104345710301240019), and does not constitute investment advice.